LENMED AIR 2019.pdf

Five-year review* Figures in ’000 ’15 ’16 ’17 ’18 ’19 ’15 ’16 ’17 ’18 ’19 ’15 ’16 ’17 ’18 ’19 ’15 ’16 ’17 ’18 ’19 REVENUE five-year CAGR* 18% ’15 ’16 ’17 ’18 ’19 HEADLINE EARNINGS five-year CAGR* 3% NORMALISED EBITDA five-year CAGR* 18% TOTAL ASSETS five-year CAGR* 22% TOTAL INTEREST- BEARING DEBT five-year CAGR* 28% CASH FLOW FROM OPERATIONS five-year CAGR* 26% R1 230 247 R1 379 225 R1 558 527 R2 220 764 R2 546 127 R127 707 R153 136 R179 263 R158 680 R143 246 R176 441 R211 605 R272 727 R399 160 R445 234 R1 600 019 R2 125 442 R3 398 692 R3 665 956 R3 972 891 R335 682 R491 452 R939 709 R1 295 444 R1 317 044 R134 224 R208 325 R253 255 R360 825 R423 625 ’15 ’16 ’17 ’18 ’19 * Calculated based on 2014 as the base year. Prior years restated. Refer to consolidated annual financial statements for further information. LENMED ANNUAL INTEGRATED REPORT 2019 07